XBiotech
XBIT | NASDAQ
$1.85
-$0.10 (-5.37%)
At close: Nov 16, 2026, 4:00 PM ET
$1.81
-$0.04 (-2.16%)
After-hours:
Nov 16, 2026, 7:21 PM ET
-5.37%
(1D)No price chart data available for 1D timeframe.
Rating
21.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #982/1021 (Top 96%)
Key Statistics
Market Data
Market Cap $56.4M
1D Range
1.81 1.97
52W Range
1.81 2.71
Valuation (TTM)
PE -1.29
PB 0.45
EV/EBITDA 1.21
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $0.00
Cash Flow
FCF Yield -72.7%
SBC Adj. FCF Yield -73.7%
SBC Impact -1.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-98.2%
Dil EPS 3Y | 5Y -15.6% |
-6.2%
FCF 3Y | 5Y -18.8% |
-26.4%
Returns
ROA -33.9%
ROE -33.0%
ROIC -37.7%
Financial Health
Net Cash
$105.04M
Current Ratio 39.51
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline...
Sector Healthcare
Industry Biotechnology
Employees 87
IPO Date Apr 15, 2015
Website www.xbiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove XBIT